Unknown

Dataset Information

0

Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.


ABSTRACT: The mechanisms of Myc-driven liver tumorigenesis are inadequately understood. Herein we show that Myc-driven hepatocellular carcinoma (HCC) is dramatically aggravated in mice with hepatocyte-specific Ptpn11/Shp2 deletion. However, Myc-induced tumors develop selectively from the rare Shp2-positive hepatocytes in Shp2-deficent liver, and Myc-driven oncogenesis depends on an intact Ras-Erk signaling promoted by Shp2 to sustain Myc stability. Despite a stringent requirement of Shp2 cell autonomously, Shp2 deletion induces an immunosuppressive environment, resulting in defective clearance of tumor-initiating cells and aggressive tumor progression. The basal Wnt/β-catenin signaling is upregulated in Shp2-deficient liver, which is further augmented by Myc transfection. Ablating Ctnnb1 suppresses Myc-induced HCC in Shp2-deficient livers, revealing an essential role of β-catenin. Consistently, Myc overexpression and CTNNB1 mutations are frequently co-detected in HCC patients with poor prognosis. These data elucidate complex mechanisms of liver tumorigenesis driven by cell-intrinsic oncogenic signaling in cooperation with a tumor-promoting microenvironment generated by disrupting the specific oncogenic pathway.

SUBMITTER: Chen WS 

PROVIDER: S-EPMC8656042 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3436956 | biostudies-literature
| S-EPMC7038122 | biostudies-literature
| S-EPMC2907087 | biostudies-other
| S-EPMC7746227 | biostudies-literature
| S-EPMC7549316 | biostudies-literature
| S-EPMC8335545 | biostudies-literature
| S-EPMC6881467 | biostudies-literature
| S-EPMC9277267 | biostudies-literature
| S-EPMC3063420 | biostudies-literature
| S-EPMC8382282 | biostudies-literature